MAPK3 and cardiac hypertrophy: Many studies [64] have shown that the activation of ERK1/2 signaling pathway plays a harmful role in myocardial remodeling, inflammation, apoptosis, oxidative stress, and other processes and is closely related to myocardial hypertrophy [65, 66].